🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 another interesting case. ✨️starting now✨️ 📿Resistant Hypertension manjusha yadla Dr. Divya Bajpai 🇮🇳 Swarnalatha Guditi Krithika Mohan

Dr. Divya Bajpai 🇮🇳 Krithika Mohan Kajaree Giri Urmila Anandh What is our BP classification? 120-130/70-90 Elevated 130-140/80-90 stage 1 >140/90 Hypertension

Dr. Divya Bajpai 🇮🇳 Krithika Mohan Kajaree Giri Urmila Anandh Dr Priti MD,FASN🇮🇳 (प्रिति) Management 1st line- DHP CCB, Thiazide,ARB or ACEi 2nd line-MRA 3rd line- Alpha blocker, beta blocker, Loop diuretics,Non DHP CCB

😳Resistant Hypertension in dialysis ✨Always consider dialyzability of drugs before prescribing Women in Nephrology-India

🤩✨Stay tuned for our upcoming Women in Nephrology-India North zone webinar On Kidney🗣️Heart/Liver Crosstalk Swarnalatha Guditi Urmila Anandh Women in Nephrology-India Smita Divyaveer, MD, DM #NephroNuggets

📢🗣️Tune in for a fantastic academic feast ! No registration needed! Just login at 5 pm IST today (22nd May 2025) #Nephrology #Nephtwitter #Medtwitter #HEART #Liver #Kidney cross talk 🔀 #WIN India #North Zone

The body is organized at various levels, cells, tissues, organs & organ systems. Dysfunction of one can affect the other & thus set off homeostasis. Join us today to explore the complexities of kidney-liver & kidney- heart crosstalk 🔗us06web.zoom.us/j/89297202751?…

Dr Sakshi Jain begins by briefing on what is cardio-renal syndrome

Several drugs are effective in CRS, with the new kids on the block joining in - SGLT2i, ARNI and MRA

MRA especially Finerenone has good potential as a standard of care in heart failure protocol & CRS, additionally the advantage of being non steroidal

manjusha yadla Kajaree Giri Dr. Ambily K Women in Nephrology-India What is our Management strategy? 🎯 prevention is 🔑 📢 Albumin >3g/dl may be detrimental Women in Nephrology-India Urmila Anandh Krithika Mohan Dr. Ambily K Medhavi Swarnalatha Guditi

manjusha yadla Kajaree Giri Dr. Ambily K Women in Nephrology-India Urmila Anandh Krithika Mohan Medhavi Swarnalatha Guditi So how do we diagnose HRS? Women in Nephrology-India Krithika Mohan manjusha yadla Urmila Anandh

manjusha yadla Kajaree Giri Dr. Ambily K Women in Nephrology-India Urmila Anandh Krithika Mohan Medhavi Swarnalatha Guditi What is out treatment strategy? Smita Divyaveer, MD, DM #NephroNuggets Urmila Anandh Women in Nephrology-India Krithika Mohan

manjusha yadla Kajaree Giri Dr. Ambily K Women in Nephrology-India Urmila Anandh Krithika Mohan Medhavi Swarnalatha Guditi Smita Divyaveer, MD, DM #NephroNuggets What is the role for Vasoconstrictor therapy? What are our options? When do we discontinue vasoconstrictors? Women in Nephrology-India Smita Divyaveer, MD, DM #NephroNuggets Swarnalatha Guditi Urmila Anandh Krithika Mohan Smita Divyaveer, MD, DM #NephroNuggets

HRS-AKI ongoing ... Take your practical tips for the day. 👌 Dr. Mahak sharing a nephrologist's perspective of HRS-AKI. Urmila Anandh Swarnalatha Guditi Krithika Mohan

Management of HRS-AKI .. Urmila Anandh Swarnalatha Guditi Krithika Mohan

👉We don't know about the exact time of the start of RRT. 👉APASAL 2024 recommends RRT in patients in stage 3 AKI within 12-24 hours (if progressive). 👉 Evidence from several trials Urmila Anandh Swarnalatha Guditi Krithika Mohan

💡Why SKLT ? 💡How does MELD score helps in SLKT ? Urmila Anandh Swarnalatha Guditi Krithika Mohan Sneha Joy

⁦Women in Nephrology-India⁩ and ⁦Women In Nephrology Africa⁩ bring their joint webinar within a few days. Please join ⁦Int Society of Nephrology⁩ ⁦Swarnalatha Guditi⁩ ⁦Charu Malik⁩ ⁦Dr Prof Manisha Sahay⁩ ⁦Dr. Divya Bajpai 🇮🇳⁩ ⁦Valerie Luyckx⁩

The ⁦Int Society of Nephrology⁩ #WCN2025 was an amazing event.⁦Women in Nephrology-India⁩ had a robust participation. Read about it all and our successful #advocacy during ⁦World Kidney Day⁩ ⁦Swarnalatha Guditi⁩ ⁦manjusha yadla⁩